Skip to main content

The key objective of the Emergen Research report is to offer a complete assessment of the global market including major leading stakeholders of the Oncological Phototherapy Market. The research study presented in this report offers complete and intelligent analysis of the competition, segmentation, dynamics, and geographical advancement of the global Oncological Phototherapy market. It takes into account the CAGR, value, volume, revenue, production, consumption, sales, manufacturing cost, prices, and other key factors related to the global Oncological Phototherapy market.

Get a Sample PDF:

The global oncological phototherapy market size reached USD 165.4 Million in 2022 and is expected to register a revenue CAGR of 8.0% during the forecast period, according to the latest analysis by Emergen Research. Increasing prevalence of cancers and rising demand for minimally non-invasive technology are some of the key factors driving revenue growth of the market over the forecast period. The National Board of Health and Welfare reports that the Cancer Registry in the U.S. received reports of 68,318 malignant tumors for 62,555 individuals in 2020. The number of individuals with a cancer diagnosis was significantly larger than the number of cancer-related fatalities.

The PESTEL, PORTER, and SWOT analyses, among other approaches, were used in the study that led to the Emergen Research report. With the aid of these models, the study clarified the important financial factors that market participants in concentrated Oncological Phototherapy need to concentrate on in order to recognise competition and create their marketing strategy for both consumer and industrial markets. The report makes use of a variety of research techniques, such as interviews, surveys, and social media monitoring, to fully examine consumer behaviour.

Scope of the Report

In this Research Report, by analysing key aspects such as profit, pricing, competition, and promotions, as well as examining, synthesizing, and summarising data from many sources, the analyst produces a comprehensive picture of the Oncological Phototherapy market. It shows a variety of market elements by identifying the top industry influencers. The data is complete, reliable, and based on extensive primary and secondary research.

Ask for Customization:

Competitive Landscape:

The most recent study offers a thorough analysis of the worldwide Oncological Phototherapy market broad competitive landscape, placing special emphasis on the major market competitors and their company profiles. The research has addressed a wide range of strategic actions done by these organisations, including new business deals, mergers and acquisitions, collaborations, joint ventures, technical advancement, and recent product introductions. The competitive environment of the market is examined in the research in several ways, including the regulatory standards and policies put in place recently across the sector. In order to provide a thorough overview of the global Oncological Phototherapy market and identify the primary growth trends, our team of specialists has made use of many potent analytical methodologies, including Porter’s Five Forces analysis and SWOT analysis.

Key Companies Profiled in the Report are:

NeoMedLight, Biolitec AG, Steba Biotech, Theralase Technologies Inc, Modulight Corporation, Soligenix, Sun Pharmaceutical Industries Ltd., Simphotek Inc., Biofrontera Inc., and Lightox Ltd

Outlook for the Region:

  • This Research Consider the following Regions:
  • North America (U.S., Canada, Mexico)
  • Europe (U.K., Italy, Germany, France, Rest of the EU)
  • Asia-Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Key Points Covered in This Section:

  • Regional contribution
  • Estimated revenue generation
  • Vital data and information about the consumption rate in all the leading regional segments
  • An expected rise in market share
  • Forecast growth in the overall consumption rate

Global Oncological Phototherapy Market Segmentation by Regions:

The countries covered in the regional analysis of the Global Oncological Phototherapy Market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.

  • Application Outlook (Revenue, USD Million; 2019-2032)

    • Skin Cancer
    • Lung Cancer
    • Esophageal (throat) Cancer
    • Others

  • End-use Outlook (Revenue, USD Million; 2019-2032)

    • Hospitals
    • Specialty Clinics

  • Regional Outlook (Revenue, USD Million; 2019–2032)

    • North America
      1. U.S.
      2. Canada
      3. Mexico
    • Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Benelux
      7. Rest of Europe
    • Asia Pacific
      1. China
      2. India
      3. Japan
      4. South Korea
      5. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • Middle East & Africa
      1. Saudi Arabia
      2. U.A.E.
      3. South Africa
      4. Turkey
      5. Rest of MEA

To get a discount on the latest report, visit:

Reasons to Purchase this Report:

  • Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region


Thank you for reading our report. Please get in touch with us if you have any query regarding the report or its customization. Our team will ensure the report is best suited to your needs.

About Us:

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research

Direct Line: +1 (604) 757-9756

E-mail: [email protected]

Visit for More Insights:
The Oncological Phototherapy (OPT) Market is gaining a lot of attention as a means of providing effective and noninvasive medical treatment for cancer and other medical conditions. OPT is a form of medical therapy that utilizes light to deliver precise doses of energy to target cells for the purpose of destroying cancerous and/or pre-cancerous cells, while minimizing the disruption of surrounding tissue. This procedure has been used for several decades for targeted photothermal thermal ablation, but with recent technological advancements, OPT has become a more feasible and effective alternative in comparison to traditional treatments.

The OPT market has undergone significant growth over the past decade, primarily due to advancements in the procedure itself and rising demand for effective, non-invasive therapies. The need for cancer treatment has steadily increased as cancer rates have risen over the past few years, making OPT increasingly popular. Market researchers suggest that the worldwide OPT market size is estimated to reach approximately US$ 4.1 billion by 2026-end. Additionally, the rising utilization of skin-related procedures, increasing incidence of benign and malignant skin disorders, and growing awareness of cancer treatments are some factors expected to drive the growth of the OPT market during the forecast period.

The OPT market is highly competitive and consists of a number of large and small companies specializing in the development and sale of OPT products, as well as those providing related services. Prominent players in the market include Medtronic, Bausch Health Companies, Lumenis, and Spectranetics, among others. These companies are significantly investing in R&D focusing on the development of more efficient and effective OPT products. For example, Medtronic developed the Optivantage AIP system which consists of advanced software, hardware, and accessories to deliver precise doses of energy to cancerous cells. They have also invested in automation technology for their OPT systems for improved accuracy and reduced time for treatments.

Despite its potential as an effective treatment for cancer and other medical conditions, OPT is still in the early stages of development, and there is a need for further research to be conducted in order to understand its full capabilities. Many of the current OPT systems rely on algorithms which require the input of a human expert in order to make informed decisions. This reduces the system’s accuracy and lengthens the treatment time. Researchers are working on ways to reduce human input and develop automated systems that can accurately identify targets and deliver accurate doses of energy. Furthermore, there is a need for greater awareness of OPT among healthcare providers and the general public. This could potentially lead to increased utilization of the procedure and further growth in the market.

In conclusion, while the OPT market is still in its early stages, it has the potential to become an integral part of future cancer treatment and other medical conditions. The recent advancements in technology and research have made OPT a more feasible and effective alternative to traditional methods of treatment, leading to its increasing popularity. As the market continues to grow, it is necessary to conduct further research in order to make the procedure more accessible and efficient, as well as increasing awareness among healthcare providers and the public.

Leave a Reply

Close Menu

Wow look at this!

This is an optional, highly
customizable off canvas area.

About Salient

The Castle
Unit 345
2500 Castle Dr
Manhattan, NY

T: +216 (0)40 3629 4753
E: [email protected]